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Objective: Adherence to treatment is important and relevant in HIV treatment. Previous studies in sub 
Sahara Africa and south western Nigeria reported that psychiatric morbidity influence treatment 
adherence. 
The present study was to examine treatment adherence among the male and the female patients with 
HIV infection and the effect of socioeconomic factors and psychiatric morbidity on treatment 
adherence .
Methods:  A total of 159 patients which comprised of 48 male and 111 female who were eligible for this 
cross sectional prospective study were included having given their consent to participate. 
Questionnaire relating to socioeconomic factors and treatment adherence were administered. 
Psychiatric morbidity was assessed using HADS. Data was analyzed with SPSS for windows version 
16.0. 
Results: Treatment adherence was poor in 5.3% of the patients. The male patients had slightly better 
adherence than the female  patients. Factors associated with poor treatment adherence include poor 
clinic attendance, presence of anxiety symptoms in males  and poor education attainment in females.
Conclusion: Treatment adherence is related to socioeconomic factors and psychiatric morbidity. 
Treatment protocol in which mental health and detailed socioeconomic circumstance of patient is an 
integral part should be encouraged.
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ABSTRACT
INTRODUCTION
treatment was reported to be very good in spite of 
2endemic poverty . The few who were non adherent 
posed danger to the community through development 
of drug resistance. 
Previous studies have shown that treatment adherence 
is affected by a number of factors such as gender, 
socioeconomic status, and psychiatric morbidity. Tapp 
3et al  reported that female gender was independently 
associated with a lower likelihood of being 95% 
adherent to antiretroviral treatment. In addition, 
female gender were less likely to start HAART 
4treatment , twice less likely to receive antiretroviral 









reatment adherence is a single modifiable 
factor in HIV infection which influenced 
disease progression and outcome. For T
instance, Stephenson reported that 81% of patients 
with more than 95% adherence demonstrated viral 
suppression while only about 6% of patients with less 
than 70% adherence showed improvement in viral 
markers. In addition short term non adherence (as 
short as 1 week) may result in rapid rebound of 
1plasma viremia, leading to treatment failure . 
However, in sub – Sahara Africa adherence to HIV 
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7Morris et al  reported that individuals who earned 
annual income <$10,000 and were not employed 
were at greater risk for treatment discontinuation. 
Also among 496 adults on antiretroviral treatment in 
rural Zambia, poor treatment adherence was 
associated with being divorced, poverty, food 
8 9insecurity and being less educated . Norman et al  
reported that co morbid psychiatric morbidity if 
untreated result in poor treatment adherence. In 
KwaZulu-Natal, depression was associated with 
poorer HAART  (Highly active antiretroviral 
10treatement) adherence  while adherence improved 
where a patient with depression were treated with 
11antidepressant . 
In a study among Yoruba dominated region of south 
western Nigeria, low medication adherence correlated 
12with presence of psychopathology . However, 
sociocultural differences among the Nigerian 
population would make it difficult to generalize their 
findings. Hence the need for this study in Hausa 
dominated north western society.
 The present study was to examine the treatment 
adherence among patients with HIV infection and to 
examine to what extent socioeconomic factors and 
psychiatric morbidity influence it in a north western 
state of the country. 
patients were asked their monthly income and 
poverty was defined by monthly income less than 
? 9,000.00 or less than ? 300.00 per day (i.e. Income 
less than $2.00 per day).
Clinic attendance and treatment adherence were 
assessed by asking the patients to rate their clinic 
attendance as follows: “how would you describe your 
clinic attendance” and “how would you describe your 
treatment adherence”. Possible responses to the former 
included: regular, occasionally missed my 
appointment, often missed my appointment and only 
come to clinic rarely while for the latter included: I 
take my drugs religiously, I do occasionally missed my 
drugs, I do often missed my drugs and I take my drugs 
poorly.  
Subjects who reported that they had regular clinic 
attendance were considered as having good clinic 
attendance while subjects who reported their clinic 
attendance as “occasionally missed appointment”, 
“often missed appointment” and “only come to clinic 
rarely” were all considered as having poor clinic 
attendance. With respect to treatment adherence, 
subjects who reported that “they take their drugs 
religiously” were considered as having good 
adherence. However, subjects with treatment 
adherence such as “occasionally missed drugs”, “often 
missed drugs” or “poorly take drugs” were all 
considered as having poor treatment adherence. The 
concept 'religiously' was introduced to denote 'regular 
and routine'. According to Cambridge dictionary 
online, 'to do things religiously' suggest 'to do things 
regularly'. This concept 'religiously' was also used to 
14describe good treatment adherence in previous report  
which suggest taking treatment on time and 
15everyday . This concept is relevant and important in 
the assessment of issues relating to routine and 
regularity in African setting because of the strong 
attachment of African to religion. 
For the assessment of psychiatric morbidity, Hospital 
16Anxiety and Depression Scale (HADS)  was used . 
17This instrument has been previously validated  and 
 13, 16 – 17 used  in previous studies in Nigeria. Using Likert 
scoring scale, score range is 0-21 for each of the 
condition. While patients with score of 0-7 were 
considered as non cases, those that scored 8-10 and 11 
and above were considered as borderline and definite 
cases for anxiety or depression.
Study design and location 
This is part of data of hospital based HIV study in 
Sokoto, Nigeria. Detailed report on methodology has 
13been described in a previous study . In this center, 
after HIV infection was confirmed using ELISA and 
western blot, irrespective of CD4 count HAART would 
be commenced. In order to ensure treatment 
adherence, a confidant, treatment partner were 
contacted. This partner could be spouse, father, child, 
or friend whose duties was to encourage and ensure 
treatment adherence. This was achieved by direct 
supervision or by telephone contacts between the 
patients and the treatment partner. 
Questionnaire was designed to assess for 
sociodemographic variables and income among the 
patients. Socioeconomic status was assessed using 
education attainment, employment status, monthly 
income and change in income since diagnosis. Also 
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METHODS
A total of one hundred and sixty seven (167) 
consecutive adult patients who attended VCT 
(Voluntary Counseling and Testing) clinic in the 
month of May 2010 were recruited for the study. Of 
these patients, 8(4.8%) did not fill HADS successfully 
to be included into the analysis giving response rate of 
95.2%. The mean age was 34.52 (±8.93) and were 
mainly Hausa by tribe (49.7%). One hundred and 
fourteen (71.7%) were married, 25 (15.7%) were 
widowed, 8 (5%) were divorced and 11 (8.9%) were 
never married. Ninety seven (61%) were Muslims and 
60 (37.7%) were Christians. In addition, seventy five 
(47.2%) were employed while about half of the total 
patients received less than ? 9000.00 per month. 
Duration of disease ranged from 2 weeks to 10 years 
while the mean duration of illness was slightly less 
than 3 years (2.97±2.58years). (Table 1).
Table 2 showed that the female were more of younger 
age group than the male with more than one third of 
them being less than 30 years when compared with 
the male patients. In addition, there was significant  
between the age of the male and the female (P = 0.00). 
Both gender also differed significantly with regard 
income (P = 0.02), employment status (P=0.00) and 
education attainment (P=0.00). Even though there 
was no significant  in treatment adherence (p = 0.68), 
the male marginally had better treatment adherence 
than the female counterpart. However they did not 
differ significantly across duration of illness since 
diagnosis (P = 0.44), change in income (P=0.48), 
score on HADS for anxiety (P=0.14) and depression (P 
= 0.84) (Table 2, 3& 4). 
Table 5 showed that more subjects who were 
widowed, 8.3% or not previously married 9.1% would 
report poor treatment adherence compared with 
subjects who were married, 4.5%. In addition no 
formal education 9.5%, being unemployed (8.7%), 
income less than ? 9000.00 (5.1%) and poor clinic 
attendance (22.2%) were all associated with poor 
treatment adherence. More subjects who were positive 
for psychiatric morbidity had poor treatment 
adherence when compared with subjects who had no 
psychiatric morbidity. For example, subjects who 
were positive for psychiatric morbidity including 
borderline anxiety 10% and definite anxiety, 7.1% were 
associated with poor treatment adherence when 
compared to subjects who were normal for anxiety. 
Similarly, poor adherence was associated with higher 
prevalence of borderline depression (14.3%) compared 
with the normal (4.8%).
Table 6 showed that being a widower among the male 
and never married among female have higher 
prevalence of poor treatment adherence. Poor 
adherence was also found to be more prevalent among 
subjects with no formal education in both the male 
and female. Unemployment was associated with 
higher prevalence of poor adherence among the male 
(12.5%) and the females (8.2%) when compared with 
others who were gainfully employed. Even though 
2there was no significant  in both males (χ  = 0.30, p = 
21.00) and the females (χ  = 0.03, p = 1.00), males who 
reported monthly income less than ? 9000.00 were 
more (9.1%) likely to report poor treatment adherence 
compared to the males who earned higher (4.3%). Poor 
adherence was significantly related to clinic 
2attendance among males (χ  = 10.23, p = 0.001) while 
among the females, though not significantly 
associated the females who reported poor clinic 
attendance were 4 times more likely to report poor 
treatment adherence.
Subjects who were anxious among males, 33.3% 
(borderline) versus 2.5% who were normal and 
females, 9.1% definite anxiety versus 5.7% who were 
normal were likely to report poor treatment 
adherence. In addition, males who were found to have 
borderline depression, 16.7% versus 2.6% who were 
normal for depression and 12.5% female with 
borderline depression versus 5.8% who were normal 
for depression reported poor treatment adherence.
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DATA ANALYSIS
Statistical analysis was done using SPSS for windows 
version 16.0 (SPSS, Chicago, Il). Continuous values 
were stated as means ± standard deviation while 
categorical data were expressed as percentages. Fisher's 
exact test was used to test for significance for 
categorical variable.  Although Pearson Chi square test 
is best used when sample size is greater than 1000, 
where Fishers exact test was unavailable, it was used. 
Means value of 2 groups were determined using 
independent t-test. For testing for significant , P-value 
less than 0.05 was considered statistically significant.
RESULT
Table 5. treatment adherence and 
patients characteristics
 Treatment adherence (%) χ2 P – value  
 Good  Poor    
Marital status     
Never married  10 (10.9) 1 (9.1) 1.28 0.73 
Married  105 (95.5) 5 (4.5)   
Divorced  7 (100) 0 (-)   
Widowed  22 (91.7) 2 (8.3)   
Education attain
ment  
    
No formal educa
tion 
38 (90.5) 4 (9.5) 5.93 0.20 
Primary  17 (100) 0 (-)   
Secondary  45 (100) 0 (-)   
Tertiary  32 (91.4) 3 (8.6)   
Postgraduate  11 (91.7) 1 (8.3)   
Are you employ
ed  
    
Yes  71 (97.3)  2 (2.7) 2.67 0.26 
No  63 (91.3) 6 (8.7)   
Income      
Income less than 
? 9000.00 
37 (94.9) 2 (5.1) 0.02 1.00 
Income greater t
han ? 9000.00 
43 (95.6) 2 (4.4)   
Attendance at th
e clinic  
    
Good  136 (96.5) 5 (3.5) 6.63 0.01 
Poor  7 (77.8) 2 (22.2)   
Psychiatric mor
bidity (anxiety) 
    
Normal  121 (95.3) 6 (4.7) 0.68 0.88 
Borderline  9 (90.0) 1 (10.0)   




    
Normal  118 (95.2) 6 (4.8) 3.03 0.39 
Borderline  12 (85.7) 2 (14.3)   
Definite depress
ion 
12 (100) 0 (0.0)   
 
36
Nigerian Journal of Medicine, Vol. 23  No.1,   January-March, 2014,  ISSN 1115-2613
Characteristics  No. (%) 
Gender   
Male  48 (30.2) 
Female  111 (69.8) 
Age class  
<20 2 (1.3) 
20-29 47 (29.9) 
30-39 66 (41.5) 
40-49 33 (20.8) 
>50 9 (5.7) 
Marital status  
Never married  11 (6.9) 
Married 114 (71.7) 
Divorced 8 (5.0) 
Widowed  25 (15.7) 
Separated  1 (0.6) 
Education  
No formal education 44 (27.8) 
Primary  19 (12.0) 
Secondary  47 (29.7) 
Tertiary  48 (30.1) 
Religion   
Islam  97 (61.8) 
Christianity  60 (37.7) 
Are you employed   
Yes  75 (49.0) 
No  73 (47.7) 
Income per month  
= ? 9000 47 (52.82) 
< ? 9000 42 (47.2) 
Clinic attendance  
Good  146 (91.8) 
Poor  12 (7.6) 
  
Treatment adherence  
Good  144 (94.7) 
Poor  8 (5.3) 
Psychiatric morbidity  
Anxiety   
No anxiety  134 (84.3) 
Borderline  10 (6.3) 
Definite anxiety  14 (8.8) 
Depression   
Normal  130 (82.3) 
Borderline  15 (9.5) 
Definite  12 (7.6) 
 
Table 1. Distribution of patients characteristics 
Table 2. Gender  and subjects' characteristics 
 Male Female χ2 P -value 
Age class     
<20 1 (2.1) 1 (0.9) 24.89 <0.00001 
20-29 6 (12.8) 41 (37.3)   
30-39 15 (31.39) 51 (46.4)   
40-49 19 (40.4) 14 (12.7)   
50-59 5 (10.6) 3 (2.7)   
Marital status     
Never married  3 (6.2) 8 (7.2) 12.84 0.012 
Married 43 (89.6) 71 (64)   
Divorced 0 (-) 8 (7.2)   
Widowed  2 (4.2) 23 (20.7)   
Separated  0 (-) 1 (0.9)   
Education     
No formal educat
ion 
9 (18.8) 35 (31.8) 20.37 0.00 
Primary  6 (12.5) 13 (11.7)   
Secondary  10 (20.8) 37 (33.6)   
Tertiary  23 (47.9) 25 (22.5)   
Religion      
Islam  30 (62.5) 67 (61.5) 0.015 1.000 
Christianity  18 (37.5) 42 (38.5)   
Are you employe
d  
    
Yes  36 (80) 39 (36.1) 24.67 0.00 
No  8 (17.8) 65 (60.2)   
Income per mont
h 
    
= ? 9000 25 (69.4) 22 (41.5)  0.017 
< ? 9000 11 (30.6) 31 (58.5)   
Change in incom
e since diagnosis 
    
Increase  2 (5.1) 1 (1.3) 2.45 0.48 
Decrease  8 (20.5) 12 (15.8)   
No  29 (74.4) 62 (81.6)   
Treatment adher
ence 
    
Good  44 (95.7) 99 (93.4) 1.50 0.68 
Poor  2 (4.3) 7 (6.6)   
Psychiatric morb
idity 
    
Anxiety      
No anxiety  42 (87.5) 92 (82.9) 1.03 0.80 
Borderline  3 (6.2) 7 (6.3)   
Definite anxiety  3 (6.2) 11 (9.9)   
Depression      
Normal  40 (83.3) 90 (81.8) 2.17 0.54 
Borderline  6 (12.5) 9 (8.2)   
Definite  2 (4.2) 10 (9.1)   
 
Table 3: A comparative study of gender  
and subjects characteristics 
 Gender  N Mean Std. Deviation Std. Error 
mean 
Age Male 47 40.57 9.67 1.41 
Female 110 31.93 7.22 0.69 
Monthly inco
me 
Male 36 28,890 35,524 5920.76 
Female 53 13,458 20,643 2835.64 
Duration in we
eks 
Male  44 155.27 123.03 18.55 
Female  73 135.97 133.30 15.60 
Anxiety score  Male  48 2.90 4.06 0.59 
Female  111 3.92 4.00 0.38 
Depression sco
re  
Male  48 4.38 3.87 0.56 
Female  111 4.24 3.81 0.36 
 
Table 4:  Test for significant  by gender
 T-test Sig. (2-tail
ed) 
Mean  Std. Error  95% confidence int
erval  
Lower  Upper 
Age  6.19 0.000 8.65 1.40  5.89 11.41 
Monthly income 2.35 0.023 15431.40 6564.77 2252.62 28610.17 
Duration(weeks) 0.78 0.437 19.30 24.73 -29.68 68.28 
Anxiety (score) -1.47 0.143 -1.02 0.69 -2.39 0.35 
Depression(score) 0.20 0.843 0.13 0.66 -1.18 1.44 
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 Good  Poor    Good  Poor    
Marital statu
s 
        
Never marri
ed  
3 (100.0) 0 (-) 10.52 0.005 7 (87.5) 1 (12.5) 1.17 0.76 
Married  40 (97.6) 1 (2.4)   65 (94.2) 4 (5.8)   
Divorced  0 (-) 0 (-)   7 (100) 0 (-)   
Widowed  1 (50.0) 1 (50)   21 (95.5) 1 (4.5)   
Education at
tainment  
        
No formal e
ducation 
8 (88.9) 1 (11.1) 2.98 0.56 30 (90.9) 3 (9.1) 5.96 0.20 
Primary  5 (100) 0 (-)   12 (100) 0 (-)   
Secondary  10 (100) 0 (-)   35 (100) 0 (-)   
Tertiary  12 (100) 0 (-)   20 (87.0) 3 (13.0)   
Postgraduate  9 (90) 1 (10.0)   2 (100) 0 (-)   
Are you em
ployed  
        
Yes  34 (97.1) 1 (2.9) 1.36 0.34 37 (97.4) 1 (2.6) 1.58 0.45 
No  7 (87.5) 1 (12.5)   56 (91.8) 5 (8.2)   




10 (90.9) 1 (9.1) 0.30 1.00 27 (96.4) 1 (3.6) 0.03 1.00 
Income grea
ter than ? 90
00.00 
22 (95.7) 1 (4.3)   21 (95.5) 1 (4.5)   
Attendance 
at the clinic  
        
Good  42 (97.7) 1 (2.3) 10.23 0.001 94 (95.9) 4 (4.1) 1.5 0.22 




        
Normal  39 (97.5) 1 (2.5) 6.52 0.04 82 (94.3) 5 (5.7) 0.72 0.87 
Borderline  2 (66.7) 1 (33.3)   7 (100) 0 (-)   
Definite anx
iety  
3 (100) 0 (-)   10 (90.9) 1 (9.1)   
Psychiatric 
morbidity  
        
(depression)         
Normal  37 (97.4) 1 (2.6) 2.55 0.28 81 (94.2) 5 (5.8) 1.35 0.72 
Borderline  5 (83.3) 1 (16.7)   7 (87.5) 1 (12.5)   
Definite dep
ression 
2 (100) 0 (-)   10 (100) 0 (-)   
 
The present study was to examine treatment adherence 
among patients who were managed for HIV infection 
in a teaching hospital in Sokoto, Nigeria. In addition, to 
determine whether socioeconomic factors and 
psychiatric morbidity affected treatment adherence 
among the male and the female patients.
The male and the female patients differed in 
sociodemographic characteristics such as age, marital 
status, education attainment and monthly earnings. 
For instance, the female subjects were younger and 
more likely to be widowed compared to the male. This 
may have implication on disease transmission as 
remarriage of young widow is frequently done 
without recourse to screening for HIV infection. Also 
more females were likely to receive no education, 
remained unemployed and earned income less than 
? 300.00 per day. However more males reported that 
their income had decreased since the onset of the illness 
DISCUSSION 
compared to the female. These findings suggested that 
the subjects in this study were likely to be poorer than 
8before the illness. Berbeck et al  reported that poverty 
contributed to mortality among patients with HIV 
infection in rural Zambia. Hence, in addition to free 
drug provided by the hospital, other services such as 
free meal and transportation could be additional 
18incentive as obtained in Tanzania . With regard to 
socioeconomic factors, marital status was included. 
This would contrast the use of only income, education 
19and employment by Falagas et al  in the assessment of 
socioeconomic state in their review. In Africa and 
particularly Nigeria, marital status affects 
socioeconomic capacity of the subjects as individuals 
who were married may receive more financial 
supports than when they were unmarried. In addition, 
social class may change on account of marriage.  
The findings in this study suggested that majority of 
the patients had good adherence to HIV treatment in 
Sokoto. However for those who had poor adherence, 
the factors associated included female gender, never 
married status, no formal education, unemployment, 
income less than ? 9000.00, poor clinic attendance, 
depression, and anxiety. 
Female patients were identified to have poor treatment 
adherence than the male. The factors associated with 
poor adherence among the female include being never 
married, no formal education, unemployment status, 
poor clinic attendance, presence of definite anxiety and 
borderline depression. However among the male, 
factors associated with poor treatment adherence 
include having no formal education, unemployed 
status, income less than N9000.00 per month, poor 
clinic  attendance, borderline anxiety and borderline 
depression.
A study reported similar finding that the female gender 
4were less likely to start HAART treatment , twice less 
5likely to receive antiretroviral treatment  and less likely 
6to adhere to treatment .  In another study among 
patients who were current or former user of opioid, 
adherence among women was 27% lower than among 
20men (46% versus 73%, P < 0.05) . 
The effects of unemployment and earning less than 
? 9000.00 monthly were associated with higher 
prevalence of treatment adherence among the male 
than the female.  The social supports received by the 
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